HBM Holdings Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HBMHF research report →
Companywww.harbourbiomed.com
HBM Holdings Limited, a clinical-stage biopharmaceutical company, engages in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. It is developing Batoclimab (HBM9161), a human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor; Tanfanercept (HBM9036) to treat moderate to-severe dry eye disease; HBM7008, a bispecific antibody targeting tumor Associated antigen; and HBM4003, a human anti-CTLA-4 antibody against cytotoxic T-lymphocyte-associated antigen-4. The company is also developing HBM9022 for the treatment of SARS-COV-2; HBM9302 for the treatment of breast and gastric cancers; HBM7020 for the treatment of multiple myeloma; and HBM1007, HBM1029, HBM7015, HBM7008, and HBM1022 for the treatment of solid tumors.
- CEO
- Jingsong Wang
- IPO
- 2022
- Employees
- 183
- HQ
- Shanghai, CN
Price Chart
Valuation
- Market Cap
- $1.30B
- P/E
- 22.67
- P/S
- 11.79
- P/B
- 3.43
- EV/EBITDA
- 19.56
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 92.85%
- Op Margin
- 43.28%
- Net Margin
- 51.67%
- ROE
- 17.09%
- ROIC
- 9.67%
Growth & Income
- Revenue
- $158.21M · 315.25%
- Net Income
- $91.47M · 3192.59%
- EPS
- $0.12 · 3233.33%
- Op Income
- $80.70M
- FCF YoY
- 128.58%
Performance & Tape
- 52W High
- $2.54
- 52W Low
- $1.10
- 50D MA
- $1.56
- 200D MA
- $2.07
- Beta
- 1.40
- Avg Volume
- 213.584
Get TickerSpark's AI analysis on HBMHF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our HBMHF Coverage
We haven't published any research on HBMHF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HBMHF Report →